Scientific Industries, Inc. (SCND)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Scientific Industries, Inc. (SCND) with AI Score 52/100 (Hold). Scientific Industries, Inc. designs, manufactures, and markets laboratory equipment and bioprocessing products. Market cap: 0, Sector: Technology.
Last analyzed: Mar 15, 2026Scientific Industries, Inc. (SCND) Technology Profile & Competitive Position
Scientific Industries, Inc. specializes in standard benchtop laboratory equipment, weight and measurement solutions, and bioprocessing systems, catering to research institutions and pharmaceutical companies. Operating in the scientific and technical instruments sector, the company distinguishes itself through its Genie and Torbal brands, offering a range of mixers, shakers, and scales.
Investment Thesis
Scientific Industries, Inc. presents a niche investment opportunity within the scientific and technical instruments sector. The company's diverse product range, including its Genie and Torbal brands, caters to a stable customer base in research and pharmaceutical industries. However, with a market capitalization of $0.01 billion and a negative profit margin of -11.7%, the company faces challenges in achieving profitability. A debt-to-equity ratio of 6.58 indicates a reliance on debt financing. Key catalysts for growth include expanding its bioprocessing systems offerings and increasing e-commerce sales. Potential risks include competition from larger players and the need for continuous innovation to maintain market relevance.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.01 billion reflects its small size within the scientific instruments market.
- Gross Margin of 42.8% indicates a solid ability to control production costs, though this needs to translate to overall profitability.
- Negative Profit Margin of -11.7% highlights the need for improved operational efficiency and cost management.
- Debt-to-Equity Ratio of 6.58 suggests a high level of financial leverage, which could pose risks if revenue growth does not materialize.
- Beta of 0.38 indicates lower volatility compared to the broader market, potentially appealing to risk-averse investors.
Competitors & Peers
Strengths
- Established brands (Genie and Torbal).
- Specialized product offerings.
- Long-standing customer relationships.
- Proprietary technology in bioprocessing.
Weaknesses
- Small market capitalization.
- Negative profit margin.
- High debt-to-equity ratio.
- Limited geographic presence.
Catalysts
- Upcoming: Expansion of bioprocessing systems product line to meet growing demand in the biotechnology and pharmaceutical industries.
- Ongoing: Increasing e-commerce sales through enhanced online platform and digital marketing efforts.
- Ongoing: Strategic partnerships with universities and research institutions to drive innovation and product adoption.
- Upcoming: Geographic expansion into the Asia-Pacific region to capitalize on growth opportunities.
- Ongoing: Investment in research and development to introduce new and innovative products.
Risks
- Ongoing: Competition from larger players with greater resources and market share.
- Potential: Technological obsolescence due to rapid advancements in laboratory equipment and bioprocessing systems.
- Potential: Economic downturns affecting R&D spending by universities and pharmaceutical companies.
- Potential: Regulatory changes in the pharmaceutical industry impacting demand for certain products.
- Ongoing: High debt-to-equity ratio posing financial risks if revenue growth does not materialize.
Growth Opportunities
- Expansion of Bioprocessing Systems: Scientific Industries can capitalize on the growing demand for bioprocessing systems in the biotechnology and pharmaceutical industries. The global bioprocessing market is projected to reach $44.6 billion by 2027, offering a significant growth opportunity. By enhancing its product offerings and expanding its customer base in this segment, Scientific Industries can drive revenue growth and improve profitability.
- E-commerce Sales Growth: Increasing direct sales through e-commerce channels can improve profit margins and expand market reach. The global e-commerce market is expected to continue its upward trajectory, providing Scientific Industries with a cost-effective way to reach end-users directly. Investing in its online platform and digital marketing efforts can drive significant sales growth.
- Strategic Partnerships: Forming strategic partnerships with universities and research institutions can provide access to new technologies and markets. Collaborating on research projects and offering customized solutions can strengthen customer relationships and drive innovation. These partnerships can also lead to increased product adoption and revenue generation.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia-Pacific, can drive revenue growth. The Asia-Pacific region is experiencing rapid growth in the biotechnology and pharmaceutical industries, creating significant demand for laboratory equipment and bioprocessing systems. Establishing a presence in this region can diversify revenue streams and reduce reliance on existing markets.
- Product Innovation: Investing in research and development to introduce new and innovative products can maintain a competitive edge. Focusing on developing advanced bioprocessing systems and laboratory equipment can attract new customers and drive sales growth. Continuous innovation is crucial for staying ahead of competitors and meeting the evolving needs of the market.
Opportunities
- Expansion of bioprocessing systems.
- Growth in e-commerce sales.
- Strategic partnerships with research institutions.
- Geographic expansion into Asia-Pacific.
Threats
- Competition from larger players.
- Technological obsolescence.
- Economic downturns affecting R&D spending.
- Regulatory changes in the pharmaceutical industry.
Competitive Advantages
- Established brands (Genie and Torbal) with a reputation for quality.
- Specialized product offerings in niche segments.
- Long-standing relationships with key customers.
- Proprietary technology in bioprocessing systems.
About SCND
Scientific Industries, Inc., founded in 1954 and headquartered in Bohemia, New York, designs, manufactures, and markets a range of laboratory equipment, weight and measurement solutions, and bioprocessing systems. The company's products are utilized across various industries, including universities, pharmaceutical companies, national laboratories, and medical device manufacturers, for research purposes. Its product portfolio includes vortex mixers, various mixers and shakers under the Genie brand, which are designed to mix the contents of test tubes, beakers, and other containers. The company also offers multi-purpose rotators and rockers, as well as magnetic stirrers. Under the Torbal brand, Scientific Industries provides pharmacy, laboratory, and industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges, and test stands products. Additionally, the company offers bioprocessing systems, including cell growth quantifiers, liquid injection systems, coaster systems, flow-through cells, multi-parameter sensors, and dissolved oxygen sensor pills. Scientific Industries sells its products through laboratory equipment distributors and directly to end-users via e-commerce, with operations spanning the United States, Germany, and other international markets.
What They Do
- Designs and manufactures standard benchtop laboratory equipment.
- Offers weight and measurement solutions under the Torbal brand.
- Provides bioprocessing systems for cell growth and monitoring.
- Sells vortex mixers and shakers under the Genie brand.
- Offers digital scales, moisture analyzers, and pill counters.
- Provides multi-parameter sensors and dissolved oxygen sensor pills.
- Markets products to universities, pharmaceutical companies, and research labs.
Business Model
- Designs, manufactures, and sells laboratory equipment and bioprocessing systems.
- Generates revenue through direct sales to end-users and distributors.
- Offers a range of products under the Genie and Torbal brands.
- Focuses on serving the research and pharmaceutical industries.
Industry Context
Scientific Industries, Inc. operates in the scientific and technical instruments industry, a sector characterized by continuous innovation and demand from research institutions, pharmaceutical companies, and healthcare providers. The market is competitive, with larger players like Thermo Fisher Scientific and Danaher Corporation dominating. Scientific Industries focuses on niche segments with its benchtop laboratory equipment and bioprocessing systems. The industry is expected to grow, driven by increasing R&D spending and advancements in biotechnology and pharmaceuticals.
Key Customers
- Universities and research institutions
- Pharmaceutical companies
- National laboratories
- Medical device manufacturers
Financials
Chart & Info
Scientific Industries, Inc. (SCND) stock price: Price data unavailable
Latest News
No recent news available for SCND.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SCND.
Price Targets
Wall Street price target analysis for SCND.
MoonshotScore
What does this score mean?
The MoonshotScore rates SCND's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Scientific & Technical InstrumentsCompetitors & Peers
SCND OTC Market Information
The OTCQB Venture Market is the middle tier of the over-the-counter (OTC) market for U.S. companies. It is distinguished from the Pink market by requiring companies to be current in their reporting, undergo an annual verification process, and meet a minimum bid price test. While it offers more visibility than the Pink market, it does not have the stringent listing requirements of exchanges like the NYSE or NASDAQ, resulting in higher risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Liquidity: OTC stocks generally have lower trading volumes, which can make it difficult to buy or sell shares quickly.
- Information Availability: While SCND maintains current disclosure, the level of scrutiny and information available may be less than that of exchange-listed companies.
- Price Volatility: OTC stocks can be more susceptible to price swings due to lower trading volumes and market capitalization.
- Regulatory Oversight: OTC markets have less regulatory oversight compared to major exchanges, increasing the risk of fraud or manipulation.
- Delisting Risk: Failure to meet OTCQB continued listing requirements could result in delisting and further reduced liquidity.
- Verify the company's financial statements and SEC filings.
- Research the management team and their track record.
- Assess the company's competitive position in its industry.
- Evaluate the company's growth prospects and potential catalysts.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Current Disclosure Status: Maintaining current reporting requirements on the OTCQB market.
- Established Business Operations: Scientific Industries has been in operation since 1954.
- Audited Financial Statements: Publicly available financial statements provide some level of transparency.
- OTCQB Listing: Being listed on the OTCQB market indicates a higher level of compliance compared to the Pink market.
- Positive Gross Margin: A gross margin of 42.8% suggests a viable business model.
Common Questions About SCND
What does Scientific Industries, Inc. do?
Scientific Industries, Inc. designs, manufactures, and markets a range of laboratory equipment, weight and measurement solutions, and bioprocessing systems. Its products, sold under the Genie and Torbal brands, are used by universities, pharmaceutical companies, and medical device manufacturers for research purposes. The company operates in the United States, Germany, and internationally, selling through distributors and directly to end-users via e-commerce. Its focus is on providing reliable and innovative tools for the scientific community.
What do analysts say about SCND stock?
As of March 15, 2026, formal analyst ratings for Scientific Industries, Inc. (SCND) are limited due to its small market capitalization and OTCQB listing. Investors should focus on the company's financial performance, including its gross margin of 42.8% and negative profit margin of -11.7%. Growth considerations include expansion of its bioprocessing systems and e-commerce sales. The high debt-to-equity ratio of 6.58 warrants careful monitoring.
What are the main risks for SCND?
The primary risks for Scientific Industries, Inc. include intense competition from larger companies in the scientific instruments sector, the potential for technological obsolescence, and the impact of economic downturns on R&D spending. The company's high debt-to-equity ratio also poses a financial risk. Furthermore, as an OTCQB-listed company, SCND faces risks related to liquidity and regulatory oversight compared to exchange-listed companies.
How exposed is Scientific Industries, Inc. to technology disruption risks?
Scientific Industries, Inc. faces moderate exposure to technology disruption risks. The scientific and technical instruments industry is characterized by continuous innovation, requiring the company to invest in research and development to stay competitive. Failure to adapt to emerging technologies and evolving customer needs could lead to market share loss. Continuous monitoring of industry trends and strategic investments in innovation are crucial for mitigating this risk.
What is Scientific Industries, Inc.'s competitive position in the tech sector?
Scientific Industries, Inc. occupies a niche position in the tech sector, focusing on benchtop laboratory equipment, weight and measurement solutions, and bioprocessing systems. While it lacks the scale and resources of larger competitors like Danaher and Thermo Fisher Scientific, its established brands (Genie and Torbal) and specialized product offerings provide a competitive advantage in specific segments. The company's ability to maintain customer relationships and innovate will be key to sustaining its position.
What are the key factors to evaluate for SCND?
Scientific Industries, Inc. (SCND) currently holds an AI score of 52/100, indicating moderate score. Key strength: Established brands (Genie and Torbal).. Primary risk to monitor: Ongoing: Competition from larger players with greater resources and market share.. This is not financial advice.
How frequently does SCND data refresh on this page?
SCND prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SCND's recent stock price performance?
Recent price movement in Scientific Industries, Inc. (SCND) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands (Genie and Torbal).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTCQB market.
- Analyst opinions are limited due to the company's size and OTC listing.